These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 4001485)
21. Drug therapy. VI. Therapy of hyperlipidemias. Holcenberg JS; Hazzard WR Northwest Med; 1970 Jul; 69(7):503-5. PubMed ID: 5469352 [No Abstract] [Full Text] [Related]
22. [A clinical research of Naoxinqing tablet's effects on blood fat and viscosity]. Wu XL; Wang MJ; Kuang Y; Zhang WJ; Ao QX Zhong Yao Cai; 2008 Jan; 31(1):171-4. PubMed ID: 18589766 [TBL] [Abstract][Full Text] [Related]
23. [Preliminary evaluation of the effect of natural water containing magnesium and calcium on changes in selected indicators of lipid metabolism in the serum of normo- and hyperlipemic persons]. Wysocki J; Chorazy M; Kalina Z; Nawrot J; Chorazy W Przegl Lek; 1987; 44(9):650-4. PubMed ID: 3438478 [No Abstract] [Full Text] [Related]
24. [Regulation effect of curcumin on blood lipids and antioxidation in hyperlipidemia rats]. Wang S; Chen B; Sun C Wei Sheng Yan Jiu; 2000 Jul; 29(4):240-2. PubMed ID: 12520931 [TBL] [Abstract][Full Text] [Related]
25. Pharmacologic treatment of dyslipidemia. McCormick JJ; Deeg MA Am J Nurs; 2000 Feb; 100(2):55-60. PubMed ID: 10683645 [No Abstract] [Full Text] [Related]
26. [Potentiation by clofibride of the heparin-induced clearing reaction (intravascular hydrolysis of neutral lipids), in hyperlipemic rabbits]. Elsair J; Marquie G; Drif M; Khelfat K; Benouniche N; Tabet Aoul M; Tabet Aoul FS; Iklef F; Ghouini A C R Seances Soc Biol Fil; 1982; 176(2):140-5. PubMed ID: 6212098 [TBL] [Abstract][Full Text] [Related]
27. [Effect of ciprofibrate on the endothelial dysfunction of patients with combined dyslipidemia]. Kovács I; Tarján J; Császár A Orv Hetil; 2001 Apr; 142(15):775-9. PubMed ID: 11367862 [TBL] [Abstract][Full Text] [Related]
28. [Atherosclerosis: some topical issues of pathogenesis, diagnosis, treatment and prevention]. Karpov RS; Dudko VA Klin Med (Mosk); 1999; 77(12):9-13. PubMed ID: 10684207 [No Abstract] [Full Text] [Related]
29. Drug treatment of hyperlipidemia. Berkowitz D Mod Treat; 1969 Nov; 6(6):1341-51. PubMed ID: 5377637 [No Abstract] [Full Text] [Related]
30. [Treatment of hyperlipemia with a new lipid decreasing drug (Ciba 13,437-Su)]. Hede S; Ditzel J; Dyerberg J Nord Med; 1970 Nov; 84(48):1539. PubMed ID: 5486044 [No Abstract] [Full Text] [Related]
32. Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome. Després JP; Lemieux I; Pascot A; Alméras N; Dumont M; Nadeau A; Bergeron J; Prud'homme D Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):702-3. PubMed ID: 12692010 [No Abstract] [Full Text] [Related]
33. [MPPG complex belongs in the first phase of drug-assisted lipid lowering (magnesium-pyridoxal-phosphate-glutamate )]. Wieland H Fortschr Med; 1990; 108 Spec No 1():52-3. PubMed ID: 2245961 [No Abstract] [Full Text] [Related]
34. [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy]. Dobiásová M; Frohlich J Vnitr Lek; 2000 Mar; 46(3):152-6. PubMed ID: 11048517 [TBL] [Abstract][Full Text] [Related]
35. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia]. Ivanova TN; Poliakova ED; Olfer'ev AM; Perova NV Biull Eksp Biol Med; 1998 May; 125(5):569-73. PubMed ID: 9644562 [No Abstract] [Full Text] [Related]
40. The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidaemic hypertensive patients. Coban E; Ozdogan M; Yazicioglu G; Sari R Int J Clin Pract; 2005 Apr; 59(4):415-8. PubMed ID: 15853856 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]